Objective: To describe the first complete response of recurrent Fallopian tube carcinoma to topotecan.
Methods: A patient with recurrent Fallopian tube carcinoma previously treated with paclitaxel (Taxol) and carboplatin is described.
Results: This patient demonstrated a complete clinical response to topotecan. Radiographic and CA-125 measurements were used to determine response. Response was noted after four cycles and a complete response demonstrated after six treatments.
Conclusion: Topotecan appears active in recurrent Fallopian tube carcinoma.
Copyright 2000 Academic Press.